Free Trial
Daniel Markowitz

Daniel Markowitz Analyst Performance

Vice President at Evercore ISI

Daniel Markowitz is a stock analyst at Evercore ISI focused in the medical sector, covering 7 publicly traded companies. Over the past year, Daniel Markowitz has issued 9 stock ratings, including strong buy, buy, and hold recommendations. While full access to Daniel Markowitz's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Daniel Markowitz's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
9 Last 0 Years
Buy Recommendations
88.89% 8 Buy Ratings
Companies Covered
7 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy11.1%1 ratings
Buy77.8%7 ratings
Hold11.1%1 ratings
Sell0.0%0 ratings

Out of 9 total stock ratings issued by Daniel Markowitz at Evercore ISI, the majority (77.8%) have been Buy recommendations, followed by 11.1% Strong Buy and 11.1% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
71.4% of companies on NASDAQ
5 companies
NYSE
28.6% of companies on NYSE
2 companies

Daniel Markowitz, an analyst at Evercore ISI, currently covers 7 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
6 companies
85.7%
Computer and Technology
1 company
14.3%

Daniel Markowitz of Evercore ISI specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
2 companies
28.6%
ELEC COMP - SEMIC
1 company
14.3%
MED INSTRUMENTS
1 company
14.3%
MEDICAL INFO SYS
1 company
14.3%
MEDICAL SERVICES
1 company
14.3%
MED/DENTAL - SUPP
1 company
14.3%

Daniel Markowitz's Ratings History at Evercore ISI

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Repligen Corporation stock logo
RGEN
Repligen
9/22/2025Upgrade$122.30$155.00Outperform
Rambus, Inc. stock logo
RMBS
Rambus
9/16/2025Boost Price Target$98.22$114.00Outperform
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
9/16/2025Initiated Coverage$114.29$155.00Outperform
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
9/2/2025Initiated Coverage$93.86$150.00Outperform
Natera, Inc. stock logo
NTRA
Natera
7/28/2025Upgrade$138.90$170.00Strong-Buy
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
7/25/2025Boost Price Target$262.83$350.00Outperform
Bio-Techne Corp stock logo
TECH
Bio-Techne
3/18/2025Initiated Coverage$62.58$75.00Outperform
Repligen Corporation stock logo
RGEN
Repligen
3/18/2025Initiated Coverage$152.81$155.00In-Line
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
3/18/2025Initiated Coverage$231.60$275.00Outperform